The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in sales , its exclusivity period created a flood of generic competition , significantly impacting its market share . While specific firms may try to capitalize on male sexual dysfunction, the curr